A comparative study between Duralabhadi Arka Domperidone Drops in management of vomiting in infantile age ( upto 1 yr)

A Randomised standard controlled clinical trial to assess the efficacy of Duralabhadi Arka in management of chhardi in ksheerapavastha (infantile age)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047787

Enrollment

Registered

2022-11-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 ksheerap shishu having sign and Symptom as mentioned in ayurvedic texts chhardi ( 2 or more episodes) with 2 or more symptoms stanyadvesh , vibandh, urdhwavata, hikka. 2 selection will be irrespective of sex religion and socio economic class, age between 0-12 months

Exclusion criteria

Exclusion criteria: 1 infant having vomiting associated with fever 2 vomiting associated with any infection of gastrointestinal tract eg gastroenteritis , respiratory system like pneumonia , urinary tract infection , central nervous system ( meningitis) 3 patients having dehydration associated with vomiting 4 known case of any anatomical defects of gastrointestinal tract 5 known case of endocrine disorder like hyperthyroidism 6 suspected patient of covid 19

Design outcomes

Primary

Measure	Time frame
Relief in vomiting episodeTimepoint: Total 3 days treatment follow up on 2nd and 3 rd day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Kishor Shivaji Bhone

PDEAs College of Ayurved and Research centre Nigdi Pune

drsudha2010@gmail.com9975404439

Outcome results